Frankfurt - Delayed Quote EUR

Formycon AG (FYB.F)

Compare
62.50
+1.00
+(1.63%)
At close: January 10 at 9:48:47 PM GMT+1
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
60,800.00
77,696.00
42,497.00
36,613.00
34,296.00
Cost of Revenue
53,223.00
54,391.00
30,426.00
26,503.00
26,365.00
Gross Profit
7,577.00
23,305.00
12,071.00
10,110.00
7,931.00
Operating Expense
32,288.00
23,674.00
29,800.00
24,110.00
14,472.00
Operating Income
-24,711.00
-369.00
-17,729.00
-14,000.00
-6,541.00
Net Non Operating Interest Income Expense
2,850.00
2,722.00
159.00
-171.00
-118.00
Pretax Income
62,308.00
79,070.00
36,596.00
-14,207.00
-6,644.00
Tax Provision
-1,589.00
3,275.00
604.00
-917.00
85.00
Net Income Common Stockholders
63,897.00
75,795.00
35,992.00
-13,290.00
-6,729.00
Diluted NI Available to Com Stockholders
63,897.00
75,795.00
35,992.00
-13,290.00
-6,729.00
Basic EPS
4.07
4.76
2.62
-1.20
-0.66
Diluted EPS
4.03
4.72
2.59
-1.20
-0.66
Basic Average Shares
16,645.90
15,915.79
13,715.22
11,042.64
10,191.78
Diluted Average Shares
16,714.36
16,048.62
13,883.87
11,170.00
10,233.27
Total Operating Income as Reported
-24,710.00
-369.00
-17,728.00
-14,000.00
-6,541.00
Total Expenses
85,511.00
78,065.00
60,226.00
50,613.00
40,837.00
Net Income from Continuing & Discontinued Operation
63,897.00
75,795.00
35,992.00
-13,290.00
-6,729.00
Normalized Income
-6,381.00
-16,392.69
58,388.16
-13,290.94
-6,729.70
Interest Income
3,198.00
2,817.00
302.00
2.00
2.00
Interest Expense
332.00
80.00
125.00
39.00
30.00
Net Interest Income
2,850.00
2,722.00
159.00
-171.00
-118.00
EBIT
62,640.00
79,150.00
36,721.00
-14,168.00
-6,614.00
EBITDA
64,702.00
81,037.00
38,583.00
-12,556.00
-5,699.00
Reconciled Cost of Revenue
53,223.00
54,391.00
30,426.00
26,503.00
26,365.00
Reconciled Depreciation
2,062.00
1,887.00
1,862.00
1,612.00
915.00
Net Income from Continuing Operation Net Minority Interest
63,897.00
75,795.00
35,992.00
-13,290.00
-6,729.00
Total Unusual Items Excluding Goodwill
82,680.00
96,171.00
-22,772.00
1.00
1.00
Total Unusual Items
82,680.00
96,171.00
-22,772.00
1.00
1.00
Normalized EBITDA
-17,978.00
-15,134.00
61,355.00
-12,557.00
-5,700.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
12,402.00
3,983.31
-375.84
0.06
0.30
12/31/2020 - 1/4/2011

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

8QQ.HM AbCellera Biologics Inc
2.8490
-1.79%
 
2160.T GNI Group Ltd.
3,085.00
-0.32%
 
MARI.VI Marinomed Biotech AG
14.70
+0.68%
 
W1H.F Onco-Innovations Limited
0.8220
-4.08%
 
4BB.L 4basebio PLC
1,250.00
0.00%
 
8QQ.F AbCellera Biologics Inc.
2.9000
+4.58%
 
SPHDF Santhera Pharmaceuticals Holding AG
9.42
0.00%
 
PI3.F Gubra A/S
86.60
-3.56%
 
ABVX.PA ABIVAX Société Anonyme
6.47
+2.21%
 
0QF.F Moderna, Inc.
41.08
-4.00%